-
Covalon Technologies Ltd. (TSXV: COV, OTCQX: CVALF)
Covalon Technologies Ltd. (TSXV: COV, OTCQX: CVALF) is a patient-driven medical device company that harnesses the power of science and technology to help the most vulnerable patients have a better chance at healing. We are a leading provider of compassionate healthcare solutions that help patients heal faster and live better.
Covalon has a strong portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings. We leverage our patented medical technology to develop products sold under Covalon’s name, and also develop and commercialize medical products for other medical organizations under development and license contracts.
We offer innovative, gentler, and more compassionate options for patients to heal with fewer infections, less pain, and better outcomes, because we care.
Follow Covalon on LinkedIn, Instagram, Twitter, Facebook and YouTube.
Brian Pedlar
President & CEO
Brian Pedlar has been President and Chief Executive Officer of Covalon since April 3, 2010 and a member of the Board of Directors since January 14, 2010. Previously, Mr. Pedlar was President of Pedlar Ventures Limited, a private venture investment and consulting firm based in Oakville, Ontario. He has served in senior executive positions with public companies including temporary Chief Financial Officer, Cygnal Technologies Corp., October 2007; President, Cedara Software Corp., 2005 to 2006; Chief Financial Officer, Cedara Software Corp., 2004 to 2005; and Director of Finance, Cedara Software Corp., 2000 to 2004. Mr. Pedlar has also held senior executive positions with Merge Healthcare and IMAX Corporation. Mr. Pedlar holds a Bachelor of Science degree from Mount Allison University and a post-graduate diploma in Accounting from Wilfrid Laurier University and is a Canadian Chartered Accountant.